FDA gives conditional approval for Avastin use by breast cancer patients.
I posted about this last week. Tom Faranda’s Folly: The FDA and cancer drug testing The FDA went against past form and approved the drug – Breast Cancer Reprieve – WSJ.com Avastin shouldn’t have been controversial. But an FDA panel ruled that "progression-free survival" was not sufficient, because the agency’s usual acid test for anticancer … Read more